Ophthalmology · Glendale, CA
NPI
1497013064
Since 2012
Specialty
Ophthalmology
Code 207W00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
1510 S Central Ave Ste 530
Glendale, CA, 91204
Phone (818) 548-5858
Groups this clinician bills Medicare through
Medicare paid, 2024
$775K
9,126 services
Medicare patients, 2024
1,685
Average age 75
Drug cost, 2024
$2.5M
8,139 prescriptions
Company payments, 2024
$185
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lilit Ablabutyan was code 92014 (ophthalmological e&m), 1,565 times for 1,153 patients. In total Lilit Ablabutyan billed 9,126 services in 59 codes, and Medicare paid $775K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-05-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92014 Ophthalmological E&M | Office | 1,565 | 1,153 | $110.47 | $173K |
| 92134 Computerized Ophthalmic Imaging | Office | 1,531 | 1,118 | $34.93 | $53K |
| 92202 Ophthalmological E&M | Office | 1,353 | 1,128 | $13.08 | $18K |
| 68761 Eye | Office | 681 | 672 | $193.22 | $132K |
| 92012 Ophthalmological E&M | Office | 493 | 278 | $78.93 | $39K |
| 92201 Ophthalmological E&M | Office | 472 | 410 | $20.99 | $9,910 |
| 92004 Ophthalmological E&M | Office | 389 | 389 | $127.50 | $50K |
| 92250 Angiography | Office | 381 | 371 | $31.39 | $12K |
| J2778 Injection, ranibizumab, 0.1 mg | Office | 380 | 15 | $126.94 | $48K |
| 92133 Computerized Ophthalmic Imaging | Office | 363 | 336 | $31.48 | $11K |
| 92136 Ultrasound - Nonspecific | Office | 241 | 219 | $41.16 | $9,919 |
| 67028 Intravitreal Injection | Office | 178 | 41 | $96.27 | $17K |
| 99204 Office E&M - New | Office | 138 | 138 | $139.61 | $19K |
| 66984 Cataract Surgery | Facility | 112 | 87 | $442.19 | $50K |
| 92083 Vision, Hearing, and Speech Services | Office | 103 | 98 | $56.71 | $5,841 |
By year: 2022 $559K for 6,225 services; 2023 $682K for 7,880 services; 2024 $775K for 9,126 services.
Medicare prescription drug claims, 2024
In 2024, the drug Lilit Ablabutyan prescribed most often to Medicare patients was Cyclosporine, with 1,709 prescriptions and refills. In total Lilit Ablabutyan wrote 8,139 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Cyclosporine Generic | 1,709 | 1,821 | 293 | $545K |
| Restasis Cyclosporine | 1,576 | 1,642 | 249 | $1.0M |
| Lumigan Bimatoprost | 667 | 788 | 96 | $219K |
| Latanoprost Generic | 532 | 613 | 76 | $2,935 |
| Azelastine Hcl Generic | 405 | 420 | 52 | $4,345 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 295 | 480 | 61 | $4,638 |
| Xiidra Lifitegrast | 276 | 276 | 41 | $188K |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 254 | 254 | 165 | $2,645 |
| Difluprednate Generic | 212 | 213 | 123 | $20K |
| Erythromycin Erythromycin Base | 206 | 206 | 87 | $1,907 |
| Timolol Maleate Generic | 171 | 258 | 38 | $2,083 |
| Besivance Besifloxacin Hcl | 159 | 159 | 103 | $35K |
| Combigan Brimonidine Tartrate/Timolol | 147 | 172 | 29 | $37K |
| Vyzulta Latanoprostene Bunod | 139 | 176 | 24 | $48K |
| Prolensa Bromfenac Sodium | 119 | 183 | 79 | $41K |
Brand drugs: 5,481 claims; generic drugs: 2,658 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Lilit Ablabutyan $185 ($185 in general payments such as food, travel and fees) from 2 companies. The largest payer was Alcon Vision LLC with $141.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.